Building-Associated Pulmonary Disease From Exposure toStachybotrys chartarum and Aspergillus versicolor
Abstract
The authors present an outbreak of disease associated with exposure to Stachybotrys chartarum and Aspergillus species. A courthouse and two associated office buildings had generated discomfort among employees for two years since initial occupancy. Multiple interventions had been unsuccessful An initial evaluation of 14 individuals identified three with potential asthma and three with symptoms consistent with interstitial lung disease. A clinical screening protocol to identify individuals who should be removed from work identified three likely and seven possible cases of building-related asthma. Detailed environmental and engineering assessments of the building identified major problems in mechanical system design, building construction, and operational strategies leading to excess moisture and elevated relative humidities. Moisture-damaged interior surfaces in both buildings were contaminated with S. chartarum, A. versicolor, and Penicillium species. Aspergillus species, especially A. versicolor, at concentrations of 10(1) to 10(4)/m3 dominated the indoor air under normal operating conditions. Bulk samples also revealed large quantities of Stachybotrys. A questionnaire survey of the three case and two control buildings documented between three- and 15-fold increases in symptoms. A nested case-control study suggested emphysematous-like disease in individuals meeting questionnaire definitions for cases. Replication of analysis strategies used in similar previous investigations suggested an association between worsening symptoms and decreased diffusing capacity of the lung. Performance on neuropsychological measures was similar for both cases and controls, although workers with symptoms reported increased levels of current but not past psychiatric symptomatology. Chemical analyses demonstrated the presence of satratoxins G and H. Cytotoxic laboratory analyses demonstrated the presence of agents with biological effectiveness in bulk materials. No association was seen between IgE or IgG antibodies and the presence of disease. This outbreak represents a likely human response to inhaled fungal toxins in indoor environments. Moisture indoors represents a public health issue currently inadequately addressed by building, health, or housing codes.
Key Biomarkers
Symptom Clusters
Cited By (47)
- Detection of AirborneStachybotrys chartarumMacrocyclic Trichothecene Mycotoxins on Particulates Smaller than ConidiaApplied and Environmental Microbiology · 2005
- The biocontaminants and complexity of damp indoor spaces: more than what meets the eyesToxicology and Industrial Health · 2009
- Occurrence of Toxigenic Aspergillus versicolor Isolates and Sterigmatocystin in Carpet Dust from Damp Indoor EnvironmentsApplied and Environmental Microbiology · 2002
- The relation between growth of four microbes on six different plasterboards and biological activity of sporesIndoor Air · 2003
- Neuropsychological performance of patients following mold exposureApplied Neuropsychology · 2002
- Clinical experience and results of a sentinel health investigation related to indoor fungal exposureEnvironmental Health Perspectives · 1999
- Cognitive impairment associated with toxigenic fungal exposure: a replication and extension of previous findings
Related Papers
- Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune ProcessesClinical Therapeutics · 2018 · 5 shared tags
- A Large Case-series of Successful Treatment of Patients Exposed to Mold and MycotoxinClinical Therapeutics · 2018 · 5 shared tags
- What effect do mycotoxins, cell wall components, enzymes and other mold components and metabolites have on our health?Allergo Journal International · 2024 · 5 shared tags
- 30+ years of knowledge creation: Indoor Air 1991–2021Indoor Air · 2022 · 5 shared tags
- Rhinitis, Ocular, Throat and Dermal Symptoms, Headache and Tiredness among Students in Schools from Johor Bahru, Malaysia: Associations with Fungal DNA and Mycotoxins in Classroom DustPLoS ONE · 2016 · 5 shared tags
- Medizinisch klinische Diagnostik bei Schimmelpilzexposition in Innenräumen – Update 2023 (AWMF-Register-Nr. 161/001)Pneumologie · 2024 · 5 shared tags